Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 38,635 $ 117,764
Short term investments 20,534 0
Accounts receivable 5,810 3,313
Prepaid expenses and other current assets 8,445 6,548
Total current assets 73,424 127,625
Property and equipment, net 16,992 19,122
Operating lease right-of-use assets 3,705 3,909
Other non-current assets 1,369 2,904
Total assets 95,490 153,560
Current liabilities:    
Accounts payable 4,154 8,609
Accrued expenses and other current liabilities 11,605 16,836
Deferred revenues, current portion 20,824 25,116
Total current liabilities 36,583 50,561
Deferred revenue, net of current portion 18,734 38,403
Operating lease liabilities 12,244 13,841
Total liabilities 67,561 102,805
Commitments and Contingencies
Stockholders’ equity:    
Convertible preferred stock, $0.001 par value per share, 10,000,000 shares authorized and 15,617 shares issued and outstanding at December 21, 2022 and 2021 0 0
Common stock, $0.001 par value per share, 300,000,000 shares authorized and 74,519,103 and 72,222,661 shares issued and outstanding at December 21, 2022 and 2021, respectively 74 72
Additional paid-in capital 318,530 306,998
Accumulated other comprehensive income (254) 829
Accumulated deficit (290,421) (257,144)
Total stockholders’ equity 27,929 50,755
Total liabilities and stockholders’ equity $ 95,490 $ 153,560